Sanofi enters talks with private equity firm to sell controlling stake in consumer health unit Opella
Fierce Pharma
OCTOBER 11, 2024
With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a deal is indeed brewing. | Sanofi has entered negotiations with private equity outfit Clayton, Dubilier & Rice to potentially sell a 50% controlling stake in its consumer health business, Opella. Sanofi first telegraphed plans to separate its consumer health arm last October.
Let's personalize your content